Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-165904
Filing Date
2024-06-21
Accepted
2024-06-21 17:24:52
Documents
16
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 6-K d832300d6k.htm 6-K 10297
2 EX-99.1 d832300dex991.htm EX-99.1 648608
3 EX-99.2 d832300dex992.htm EX-99.2 24497
4 EX-99.3 d832300dex993.htm EX-99.3 13040
5 GRAPHIC g832300dsp38.jpg GRAPHIC 78209
6 GRAPHIC g832300g0620032547492.jpg GRAPHIC 3610
7 GRAPHIC g832300g0620032547717.jpg GRAPHIC 12684
8 GRAPHIC g832300g0620032547886.jpg GRAPHIC 10251
9 GRAPHIC g832300g0620032548042.jpg GRAPHIC 13548
10 GRAPHIC g832300g0620032548997.jpg GRAPHIC 25009
11 GRAPHIC g832300g0620032549568.jpg GRAPHIC 9885
12 GRAPHIC g832300g0620032551406.jpg GRAPHIC 2889
13 GRAPHIC g832300g0621224134094.jpg GRAPHIC 2742
14 GRAPHIC g832300g0621224455041.jpg GRAPHIC 1977
15 GRAPHIC g832300g91l87.jpg GRAPHIC 14474
16 GRAPHIC g832300g96w59.jpg GRAPHIC 9149
  Complete submission text file 0001193125-24-165904.txt   942591
Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3
Business Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3 14039485227
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39005 | Film No.: 241061453
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)